NewLeaf Symbiotics Funding: $122M Raised, Series D (2023)
NewLeaf Symbiotics is a Biotech company based in St. Louis, Missouri. It has raised $122M in total funding. Latest round: Series D.
NewLeaf Symbiotics funding overview
NewLeaf Symbiotics is a Biotech company based in St. Louis, Missouri. NewLeaf Symbiotics has raised $122M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2023. The round record for NewLeaf Symbiotics runs through 2023; nothing later has been disclosed. Investors on record include Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital. 5 distinct backers are named across the disclosed rounds.
NewLeaf Symbiotics at a glance
Total raised
$122M
Latest round
Series D
Latest round date
December 2023
Industry
Biotech
Headquarters
St. Louis, Missouri
Notable investors
Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital
Frequently asked about NewLeaf Symbiotics funding
How much has NewLeaf Symbiotics raised?
NewLeaf Symbiotics has raised $122M in total disclosed funding across the rounds on record.
Who has invested in NewLeaf Symbiotics?
Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital are named among the investors backing NewLeaf Symbiotics.
What was the latest NewLeaf Symbiotics funding round?
The most recent disclosed round is a Series D, announced in December 2023.
Where is NewLeaf Symbiotics based?
NewLeaf Symbiotics is based in St. Louis, Missouri.
What sector does NewLeaf Symbiotics operate in?
NewLeaf Symbiotics is tracked under Biotech from St. Louis, Missouri, with $122M in disclosed funding.
When did NewLeaf Symbiotics last raise?
The last disclosed NewLeaf Symbiotics round closed in December 2023 at Series D.
NewLeaf Symbiotics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in St. Louis below to benchmark round size and investor mix.
